Susquehanna International Group, LLP Alaunos Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$0.04 - $0.13 $60 - $195	-1,500 Reduced 4.19%	34,300 $2,000
Q3 2023 Nov 14, 2023	SELL	$0.12 - $0.5 $420 - $1,750	-3,500 Reduced 8.91%	35,800 $4,000
Q2 2023 Aug 11, 2023	BUY	$0.43 - $0.65 $1,333 - $2,015	3,100 Added 8.56%	39,300 $20,000
Q1 2023 May 16, 2023	SELL	$0.46 - $0.81 $6,302 - $11,097	-13,700 Reduced 27.45%	36,200 $22,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $261.0 $108,900 - $56.8 Million	-217,800 Reduced 81.36%	49,900 $32,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $207,376 - $64.3 Million	199,400 Added 291.95%	267,700 $460,000
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $11,316 - $34,224	-27,600 Reduced 28.78%	68,300 $85,000
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $81,220 - $153,270	-131,000 Reduced 57.73%	95,900 $62,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.89 $62,566 - $108,486	-57,400 Reduced 20.19%	226,900 $247,000
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $34,128 - $64,701	-23,700 Reduced 7.69%	284,300 $517,000
Q2 2021 Aug 11, 2021	BUY	$2.63 - $3.67 $8,416 - $11,744	3,200 Added 1.05%	308,000 $813,000
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $293,562 - $582,960	104,100 Added 51.87%	304,800 $1.1 Million
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $63,117 - $93,318	-30,200 Reduced 13.08%	200,700 $506,000
Q3 2020 Nov 16, 2020	SELL	$2.39 - $3.43 $784,876 - $1.13 Million	-328,400 Reduced 58.72%	230,900 $582,000
Q2 2020 Aug 14, 2020	SELL	$2.2 - $3.71 $212,520 - $358,386	-96,600 Reduced 14.73%	559,300 $1.84 Million
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $1.1 Million - $2.88 Million	579,000 Added 752.93%	655,900 $1.61 Million
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $1.63 Million - $2.2 Million	-411,500 Reduced 84.25%	76,900 $363,000
Q3 2019 Nov 14, 2019	SELL	$4.13 - $6.94 $1.17 Million - $1.96 Million	-282,400 Reduced 36.64%	488,400 $2.09 Million
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $255,914 - $398,660	64,300 Added 9.1%	770,800 $4.49 Million
Q1 2019 May 15, 2019	BUY	$2.0 - $4.4 $793,600 - $1.75 Million	396,800 Added 128.12%	706,500 $2.72 Million
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $324,415 - $729,430	201,500 Added 186.23%	309,700 $579,000
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $23,503 - $34,008	-10,400 Reduced 8.77%	108,200 $346,000
Q2 2018 Aug 14, 2018	BUY	$3.02 - $4.94 $77,614 - $126,958	25,700 Added 27.66%	118,600 $358,000
Q1 2018 May 15, 2018	SELL	$3.46 - $5.14 $274,724 - $408,116	-79,400 Reduced 46.08%	92,900 $364,000
Q4 2017 Feb 14, 2018	SELL	$4.0 - $6.54 $425,200 - $695,202	-106,300 Reduced 38.16%	172,300 $713,000
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $1.39 Million - $1.83 Million	278,600	278,600 $1.71 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $517M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account